Pharma & Biotech Inside Biotech: China’s biopharma engine is reshaping global dealmaking By Proactive 28/01
Financial Services Three things to watch in the week ahead: Big tech earnings, AU CPI & Fed rate decision By Proactive 27/01
Financial Services Power Metallic Mines catches analyst attention after strong metallurgical results from Lion Zone By Proactive 26/01
Finance Week ahead: Big Tech, the Fed and plenty of cross-currents set the tone for Wall Street By Proactive 26/01
Pharma & Biotech Tech Bytes: FDA update reshapes the multiple myeloma development playbook By Proactive 23/01
Retail & consumer Surprise December jobs surge sharpens focus on February RBA meeting By Proactive 22/01
Gold & silver G Mining Ventures outlook positive despite higher costs, Jefferies says By Proactive 21/01
Gold & silver TNR Gold nears first royalty revenue as lithium, copper markets surge: analysts By Proactive 21/01
Pharma & Biotech Inside Biotech: Mesoblast slips as FDA feedback meets market reality By Proactive 19/01
Hardware & electrical equipment Tech Bytes: TSMC steadies the AI trade after a shaky week By Proactive 16/01
Pharma & Biotech Inside Biotech: Neuren snaps back after rally — what’s priced in now? By Proactive 15/01